Elekta Unveils Breakthrough Radiotherapy Innovations at CIIE to Advance New Quality Productive Forces in Radiation Oncology

11Month5Recently, the 7th China International Import Expo (CIIE) kicked off in grand style. As a global pioneer in precision radiotherapy, Elekta has participated in the event for seven consecutive years,and with“Global Pioneer in Precision Radiotherapy, Advancing High-Quality Radiotherapy Development”as the theme, making another appearance at this grand event and unveiling multiple groundbreaking innovative technologies for the first time, demonstrating its determination and strength in continuously empowering China's healthcare sector.

Elekta Booth at the 2024 CIIE

Elekta Empowers the Cultivation of New-Quality Productive Forces in Radiotherapy Through Technological Innovation:Elekta Evo, the intelligent adaptive integrated radiotherapy platform making its Asian debut; Elekta ONE, the smart radiotherapy platform making its Chinese debut; and Elekta Unity 3.0, the new-generation high-field MRI-guided radiotherapy system making its Asia-Pacific debut.

Elekta Evo Intelligent Adaptive Integrated Radiotherapy Platform: Delivering Unlimited Clinical Freedom Through a One-Stop Comprehensive Solution, Empowering Clinicians to Flexibly Address Multiple Indications, Provide Personalized Treatment for Every Patient, and Explore the Boundless Potential of Precision Radiotherapy.

Leveraging Iris high-definition AI-enhanced imaging technology, the Elekta evo delivers high-resolution, true-to-life images, enabling clinicians to gain deep insights into lesions and fully meet both routine clinical treatment needs and special requirements. Meanwhile, powered by the multi-dimensional Elekta ONE platform, it achieves comprehensive enhancements ranging from functional modules to treatment workflows. Furthermore, the platform supports full-featured online and offline adaptive capabilities, facilitating flexible decision-making and ensuring higher quality and efficiency in clinical treatments.

On-Site Launch of the Elekta Evo Intelligent Adaptive Integrated Radiotherapy Platform

Elekta ONE Intelligent Radiotherapy Platform is a highly integrated software solution. By incorporating the most innovative features and solutions from Elekta’s oncology software portfolio, Elekta ONE delivers accelerated innovation, a smoother user experience, and a unified user interface. It makes streamlined, intelligent, data-driven workflows accessible anytime and anywhere, empowering clinicians to easily implement various cancer treatment modalities and thereby significantly improving patient outcomes.

 Elekta ONE Intelligent Radiotherapy Platform

Elekta Unity 3.0: The New Generation of High-Field MRI-Guided Radiotherapy System Breaks the Limitations of Traditional Treatment Models with Three Pioneering “First-of-Its-Kind” Technologies, Elevating Precision Radiotherapy to New Heights.

Pioneering high-field Magnetic Resonance-guided Adaptive Radiotherapy (MRgRT), which leverages advanced MRI technologies such as onboard 3D vaneXD and compressed sensing to achieve ultra-fast, ultra-clear imaging guidance during treatment, offering unprecedented new perspectives; pioneering Biology-guided Adaptive Radiotherapy (BgRT), which captures biological changes in tumors during treatment in real time, enabling earlier guidance and intervention for treatment plan adjustments, enhancing therapeutic efficacy, and opening new frontiers in clinical treatment; pioneering the Comprehensive Motion Management (CMM) solution, which unlocks the real-world dynamics of tumor motion during treatment for the first time, achieving true tumor tracking and utilizing artificial intelligence to automatically predict tumor motion trajectories and correct timing errors, thereby realizing automatic gating for precise irradiation and leading radiotherapy into a new era of real-time adaptive radiotherapy.

Elekta Unity 3.0: Next-Generation High-Field MR-Guided Radiotherapy System

Furthermore, the Elekta booth features a dedicated Brachytherapy Solutions Zone, showcasing brachytherapy systems—the gold standard for treating cervical cancer—and X-ray brachytherapy systems that make intraoperative radiation therapy for breast cancer readily accessible; as well as a Neuroscience Solutions Zone, presenting Elekta’s new generation of intelligent stereotactic radiosurgery systems.

Elekta’s latest-generation Flexitron HDR high-dose-rate (HDR) brachytherapy system offers more specialized treatment options for tumors in various parts of the body, enabling safer, more precise, and more efficient brachytherapy. Elekta Xoft features a unique X-ray brachytherapy technology that innovatively employs miniature low-energy X-ray tubes instead of radioactive isotopes to irradiate tumors, delivering significant advantages including high biological effectiveness, superior dose distribution, and favorable treatment timeliness. It is currently primarily used in the treatment of breast cancer, non-melanoma skin cancer, and gynecological tumors. Elekta’s new-generation intelligent stereotactic radiosurgery system, Elekta Esprit, adheres to a patient-centered principle. With exceptional treatment precision, it treats brain diseases while maximizing the protection of surrounding healthy tissues. It not only saves lives but also safeguards patients’ brains, preserving motor, sensory, and neurocognitive functions.

In addition to its pioneering technologies, as an enabler of China’s radiotherapy ecosystem, Elekta will showcase new collaborative initiatives with industry partners at the China International Import Expo (CIIE), including a major announcement on the first day: the establishment of the Sinopharm-Elekta-Dongfeng General Hospital International Training Center, further underscoring Elekta’s steadfast commitment to “In China, For China.”

Gustaf Salford, President and Chief Executive Officer of Elektastated: “As a long-standing and trusted partner in China’s radiation oncology sector, Elekta looks forward to seeing innovative technologies take root in the Chinese market, thereby benefiting more patients. Meanwhile, we hope that local cases and experience in China will serve as ‘Chinese wisdom’ worthy of reference, further leveraging Elekta’s global footprint to help elevate the standard of radiation therapy worldwide.”

Gong Anming, Global Executive Vice President and President of China Region at Elektastated, “‘Going all out for life’ is Elekta’s unwavering pursuit. We continue to introduce globally leading radiotherapy technologies into China, aiming to further promote the widespread availability of standardized, high-quality radiotherapy services. Meanwhile, we will continue to collaborate with industry partners to build a robust radiotherapy ecosystem, consistently contributing to ‘Healthy China 2030’ and driving China’s radiotherapy industry to new heights.”